ANI Pharmaceuticals (ANIP)

[LordDarley]

Jeff,

I don't really have an assessment that would be worth repeating, other than what I posted most recently. With Corti approval, I see this company trading at 15 x GAAP earnings in a few years, which has me pretty close (at 120) to the 127 estimate from the Gurus.

My knowledge of the medical/scientific space (although I work with lots of hospitals and medical groups) is not at a level where my input on the science and its financial value would be worth too much.

ANIP has been an experiment, not too succesful to date, but I can be patient and would love more shares to reduce my stupidly optmistic basis of $60/share.

Don't laugh too hard. It only hurts when I tell Lady Darley. What goes on at Investors Hub stays here. (I hope.)